More Zelira Therapeutics Ltd. news Zelira Therapeutics Ltd.ASX: ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial Nov 21, 2022 at 3:02 AM UTC · Issued by Zelira Therapeutics Ltd. As issuedPlain English Zelira Therapeutics Ltd has released a press release. View Attachment